83
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Heat-induced growth inhibition and apoptosis in transplanted human head and neck squamous cell carcinomas with different status of p53

, , , , , , , & show all
Pages 590-597 | Received 15 Oct 2002, Accepted 26 Apr 2003, Published online: 09 Jul 2009

References

  • Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957–67.
  • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805–16.
  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor sup-pression. Cell 1993; 75: 817–25.
  • Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apop-tosis. Nature 1997; 389: 300–5.
  • Wang X, Ohnishi T. p53-Dependent signal transduction induced by stress. J Radiat Res 1997; 8: 179–94.
  • Kato F, Kakihara H, Kunigita N, Ootsuyama A, Norimura T. Role of p53 gene in apoptotic repair of genetoxic tissue damage in mice. J Radiat Res 2002; 43: S209–12.
  • Ohnishi T, Wang X, Ohnishi K, Matsumoto H, Takahashi A. p53-Dependent induction of WAF1 by heat treatment in human glioblastoma cells. J Biol Chem 1996; 271: 14510–3.
  • Ohnishi K, Wang X, Takahashi A, Ohnishi T. Contribution of protein kinase C to p53 dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines. Exp Cell Res 1998; 238: 399–406.
  • Ohnishi T, Wang X, Ohnishi K, Takahashi A. p53-Dependent induction of WAF1 by cold shock in human glioblastoma cells. Oncogene 1998; 16: 1507–11.
  • Ohtsubo T, Wang X, Takahashi A, Ohnishi K, Saito H, Song CW, Ohnishi T. p53-Dependent induction of WAF1 by a low-pH culture condition in human glioblastoma cells. Cancer Res 1997; 57: 3910–3.
  • Homma A, Furuta Y, Oridate N, Nakano Y, Kahashi G, Yagi K, Nagahashi T, Yagi K, Nagahashi T, Fukuda S, Inoue K, Inuyama Y. Prognostic significance of clinical para-meters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Clin Cancer Res 1999; 5: 801–6.
  • King TC, Akerley W, Fan AC, Moore T, Mangray S, Hsiu Chen M, Safran H. p53 mutations do not predict to paclitaxel in metastatic nonsmall cell lung cancer. Cancer 2000; 89: 769–73.
  • Lowe SW. Cancer therapy and p53. Curr Opin Oncol 1995; 7: 547–53.
  • Kitamura K, Kuwano H, Watanabe M, Nozoe T, Yasuda M, Sumiyoshi K, Saku M, Sugimachi K. Prospective randomized study of hyperthermia combined with chemora-diotherapy for esophageal carcinoma. J Surg Oncol 1995; 60: 55–8.
  • Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int .1 Hypertherrnia 1994; 10: 485–93.
  • van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet 2000; 355: 1119–25.
  • Harima Y, Nagata K, Harima K, Oka A, Ostapenko VV, Shikata N, Ohnishi T, Tanaka Y. Bax and Bc1-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma. Cancer 2000; 88: 132–8.
  • Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994; 73: 2048–52.
  • Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998; 40: 287–95.
  • Ota I, Ohnishi K, Takahashi A, Yane K, Kanata H, Miyahara H, Ohnishi T, Hosoi H. Transfection with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2000; 47: 495–501.
  • Matsumoto H, Takahashi A, Wang X, Ohnishi K, Ohnishi T. Transfection of p53-knock-out mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress. Int J Radiat Oncol Biol Phys 1997; 38: 1089–95.
  • Yano T, Nakatani K, Watanabe A, Nakano H, Ohnishi T. Effects of pre-heating on cis-diamminedichloroplatinum (II)-hyperthermia-induced tumor growth depression of transplantable human oesophageal cancer to nude mice. Int J Hypertherrnia 1993; 9: 699–708.
  • Ohnishi T, Takahashi A, Yano T, Matsumoto H, Wang X, Ohnishi K, Tamamoto T, Tsuji K, Furusawa Y, Yukawa 0. Hyperthermic enhancement of tumor growth inhibition by accelerated carbon-ions in transplantable human esophageal cancer. Int J Hypertherrnia 1998; 14: 195–202.
  • Asakawa I, Hitoshi Y, Takahashi A, Ohnishi K, Nakagawa H, Ota I, Furusawa Y, Tamamoto T, Ohishi H, Ohnishi T. Radiation-induced growth inhibition in transplanted human Tongue carcinomas with different p53 gene status. Anticancer Res 2002; 22: 2037–44.
  • Abiko Y, Arai J, Mitamura J, Kaku T. Alteration of proto-oncogenes during apoptosis in the oral squamous cell carcinoma cell line, SAS, induced by staurosporine. Cancer Lett 1997; 118: 101–7.
  • Mukhopadhyay D, Tasiokas L, Sukhatme VP. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995; 55: 6161–5.
  • Nishizaki M, Fujiwara T, Tanida T, Hizuta A, Nishimori H, Tokino T, Nakamura Y. Bouver M, Roth JA, Tanaka N. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. Clin Cancer Res 1999; 5: 1015–23.
  • Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppres-sion of vascular endothelial growth factor expression. Cancer Res 2000; 60: 3655–61.
  • Kieser A, Weich HA, Brandner G, Marme D, Koich W. Mutant p53 potentiates protein kinase C inhibitor of vascular endothelial growth factor expression. Oncogene 1994; 9: 963–9.
  • Reich NC, Oren M, Levine Ai. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol 1983; 3: 2143–50.
  • Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 1992; 256: 827–30.
  • Ohtsubo T, Park Ill, Lyons JC, Ohnishi T, Song CW. Effect of acidic enviroment and p53 on apoptosis induced by hyperthermia. Int J Hypertherrnia 2000; 16: 481–91.
  • Freeman ML, Borrelli MJ, Meredith MJ, Lepock JR. On the path to the heat shock response: destabilization and formation of partially folded protein. Free Radic Biol Med 1999; 26: 737–45.
  • Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. Int J Hypertherrnia 1995; 11: 459–88.
  • Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 1997; 17: 5317–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.